InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Clemmer James C, Chairman & CEO. Insider active across 1 companies, notably Angiodynamics INC. Cumulatively, 12 reports have been logged. Total volume traded: €403k. The latest transaction was filed on 11 January 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
€201,58110,000 shares@ €20.15810.045% mcap57.4% of flow
Common Stock
SEC:0001567619-22-001113·
Ideal exit: 8 Oct 2022 (T+270)
€201,58110,000 shares@ €20.15810.045% mcap28.7% of flow
Common Stock
SEC:0001567619-22-001113:0·
Ideal exit: 8 Oct 2022 (T+270)
037,420 shares0
Common Stock
SEC:0001567619-21-022713·
037,420 shares0
Common Stock
SEC:0001567619-21-022713:0·
040,528 shares0
Common Stock
SEC:0001567619-21-016023·
040,528 shares0
Common Stock
SEC:0001567619-21-016023:0·
019,387 shares0
Common Stock
SEC:0001567619-21-015951·
019,387 shares0
Common Stock
SEC:0001567619-21-015951:0·
€46,5292,105 shares@ €22.10410.010% mcap13.2% of flow
Common Stock
SEC:0001567619-21-014055·
€46,5292,105 shares@ €22.10410.010% mcap6.6% of flow
Common Stock
SEC:0001567619-21-014055:0·
€103,2334,622 shares@ €22.33520.023% mcap29.4% of flow
Common Stock
SEC:0001567619-21-013917·
€103,2334,622 shares@ €22.33520.023% mcap14.7% of flow
Common Stock
SEC:0001567619-21-013917:0·
12 of 12 declarations
About Clemmer James C
James C. Clemmer is the President and CEO of ANGIODYNAMICS INC. He leads the company by implementing strategies to enhance performance and achieve growth objectives. His leadership is essential for the development of innovative products and market expansion.
